Inhibition of hepatitis B virus production associated with high levels of intracellular viral DNA intermediates in iron-depleted HepG2.2.15 cells

被引:21
作者
Chouteau, P [1 ]
Le Seyec, J [1 ]
Saulier-Le Dréan, B [1 ]
Cannie, T [1 ]
Brissot, P [1 ]
Lescoat, G [1 ]
Guguen-Guillouzo, C [1 ]
Gripon, P [1 ]
机构
[1] Hop Pontchaillou, INSERM U522, F-35033 Rennes, France
关键词
hepatitis B virus; iron-depletion; desferrioxamine; hydroxyurea; cell cycle; DNA replication;
D O I
10.1016/S0168-8278(00)00012-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Backgrounds/Aims: The effects of iron-depletion on hepatitis B virus (HBV) replication were examined in HepG2.2.15 cells. Methods: Proliferating cells were iron-depleted with desferrioxamine (DFO), at 20 or 100 muM for 48 h. Levels of viral mRNAs, cytoplasmic DNA replicative intermediates and virion production were examined. A comparative study was performed with hydroxyurea, a specific inhibitor of ribonucleotide reductase. Results: In desferrioxamine treated cells, virion production is dramatically decreased, while viral replicative intermediates accumulate in the cytoplasm, DFO, like hydroxyurea, blocks cell cycle progression in the G1/S transition or S phase with a corresponding 2-fold increase of viral mRNAs. As expected, hydroxyurea leads to a strong reduction of virion production associated with low levels of intracellular replicative intermediates, Conclusions: These results strongly suggest that iron depletion affects the HDV life cycle indirectly through the cell cycle arrest and directly through the inhibition of the viral DNA secretion. They also Indicate the need to re-evaluate with caution the iron depletion protocols on HBV infected patients since a decrease of viral markers in the serum following iron-depletion may not reflect a decrease of viral replicative forms, but on the contrary, could be associated with active viral DNA synthesis. (C) 2001 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:108 / 113
页数:6
相关论文
共 36 条
[1]   A SIMPLE AND RAPID PROCEDURE FOR PREPARATION OF LARGE QUANTITIES OF PURE OVOTRANSFERRIN [J].
AZARI, P ;
BAUGH, RF .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1967, 118 (01) :138-&
[2]  
Bayraktar Y, 1998, HEPATO-GASTROENTEROL, V45, P2322
[3]   The use of deferoxamine infusions to enhance the response rate to interferon-alpha treatment of chronic viral hepatitis B [J].
Bayraktar, Y ;
Koseoglu, T ;
Sommer, C ;
Kayhan, B ;
Temizer, A ;
Uzunalimoglu, B ;
DeMaria, N ;
VanThiel, DH .
JOURNAL OF VIRAL HEPATITIS, 1996, 3 (03) :129-135
[4]   PLASMODICIDAL EFFECT OF DESFERRIOXAMINE-B IN HUMAN VIVAX OR FALCIPARUM-MALARIA FROM THAILAND [J].
BUNNAG, D ;
POLTERA, AA ;
VIRAVAN, C ;
LOOAREESUWAN, S ;
HARINASUTA, KT ;
SCHINDLERY, C .
ACTA TROPICA, 1992, 52 (01) :59-67
[5]   IN-VITRO INHIBITION OF HUMAN CYTOMEGALOVIRUS REPLICATION BY DESFERRIOXAMINE [J].
CINATL, J ;
CINATL, J ;
RABENAU, H ;
GUMBEL, HO ;
KORNHUBER, B ;
DOERR, HW .
ANTIVIRAL RESEARCH, 1994, 25 (01) :73-77
[6]   The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase [J].
Cooper, CE ;
Lynagh, GR ;
Hoyes, KP ;
Hider, RC ;
Cammack, R ;
Porter, JB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) :20291-20299
[7]   MIMOSINE INHIBITS VIRAL-DNA SYNTHESIS THROUGH RIBONUCLEOTIDE REDUCTASE [J].
DAI, YM ;
GOLD, B ;
VISHWANATHA, JK ;
RHODE, SL .
VIROLOGY, 1994, 205 (01) :210-216
[8]  
EHRENBERG A, 1972, J BIOL CHEM, V247, P3485
[9]   PLASMODIUM-VINCKEI - SUPPRESSION OF MOUSE INFECTIONS WITH DESFERRIOXAMINE-B [J].
FRITSCH, G ;
TREUMER, J ;
SPIRA, DT ;
JUNG, A .
EXPERIMENTAL PARASITOLOGY, 1985, 60 (02) :171-174
[10]   IRON DEPRIVATION DECREASES RIBONUCLEOTIDE REDUCTASE-ACTIVITY AND DNA-SYNTHESIS [J].
FURUKAWA, T ;
NAITOH, Y ;
KOHNO, H ;
TOKUNAGA, R ;
TAKETANI, S .
LIFE SCIENCES, 1992, 50 (26) :2059-2065